174671-50-2Relevant articles and documents
Synthesis, structure, properties and antimicrobial activity of para trifluoromethyl phenylboronic derivatives
Adamczyk-Wo?niak, Agnieszka,Tarkowska, Magdalena,Lazar, Zofia,Kaczorowska, Ewa,Madura, Izabela D.,Maria D?browska, Anna,Lipok, Jacek,Wieczorek, Dorota
, (2021/12/23)
The [2-formyl-4-(trifluoromethyl)phenyl]boronic acid as well as its benzoxaborole and bis(benzoxaborole) derivatives were obtained and their properties studied. The 2-formyl compound displays an unusual structure in the crystalline state, with a significa
BORON-CONTAINING SMALL MOLECULES AS ANTI-INFLAMMATORY AGENTS
-
Page/Page column 41; 44, (2008/06/13)
Methods of treating anti-inflammatory conditions through the use of boron-containing small molecules are disclosed.
Compounds for the Treatment of Periodontal Disease
-
Page/Page column 44; 47, (2008/06/13)
Compounds, compositions and methods are provided which are useful in the treatment of periodontal disease.
Boron-containing small molecules
-
Page/Page column 30, (2008/06/13)
This invention relates to compounds useful for treating fungal infections, more specifically topical treatment of onychomycosis and/or cutaneous fungal infections. This invention is directed to compounds that are active against fungi and have properties that allow the compound, when placed in contact with a patient, to reach the particular part of the skin, nail, hair, claw or hoof infected by the fungus. In particular the present compounds have physiochemical properties that facilitate penetration of the nail plate.
Discovery of a new boron-containing antifungal agent, 5-fluoro-1,3-dihydro- 1-hydroxy-2,1-benzoxaborole (AN2690), for the potential treatment of onychomycosis
Baker, Stephen J.,Zhang, Yong-Kang,Akama, Tsutomu,Lau, Agnes,Zhou, Huchen,Hernandez, Vincent,Mao, Weimin,Alley,Sanders, Virginia,Plattner, Jacob J.
, p. 4447 - 4450 (2007/10/03)
A structure-activity relationship investigation for a more efficacious therapy to treat onychomycosis, a fungal infection of the toe and fingernails, led to the discovery of a boron-containing small molecule, 5-fluoro-1,3-dihydro- 1-hydroxy-2,1-benzoxaborole (AN2690), which is currently in clinical trials for onychomycosis topical treatment.